BRUIN CLL-321: Randomized phase III trial of pirtobrutinib versus idelalisib+rituximab or bendamustine+rituximab in BTKi-pretreated CLL/SLL Meeting Abstract
| Authors: | Sharman, J. P.; Munir, T.; Grosicki, S.; Roeker, L. E.; Burke, J. M.; Chen, C.; Grzasko, N.; Follows, G.; Mátrai, Z.; Sanna, A.; Yi, S.; Hua, V. M.; Feng, R.; Holodja, J.; Jurczak, W.; Ritgen, M.; Qiu, L.; Bosch, F.; Coombs, C. C.; Bao, K.; Patel, V.; Liu, B.; Compt, L.; Guntur, A.; Wang, D. Y.; Hill, M.; Leow, C. C.; Ghia, P.; Barr, P. M.; Chan, T. W. |
| Abstract Title: | BRUIN CLL-321: Randomized phase III trial of pirtobrutinib versus idelalisib+rituximab or bendamustine+rituximab in BTKi-pretreated CLL/SLL |
| Meeting Title: | 65th Annual Scientific Meeting of the British Society for Haematology (BSH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 206 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2025 Apr 27-29 |
| Meeting Location: | Glasgow, Scotland |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2025-04-01 |
| Language: | English |
| ACCESSION: | WOS:001517858300220 |
| PROVIDER: | wos |
| DOI: | 10.1111/bjh.20117 |
| Notes: | Meeting Abstract: PO84 -- Source: Wos |
